UK markets closed

Biotest Aktiengesellschaft (0N70.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
26.80+0.30 (+1.13%)
At close: 11:02AM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.26
52-week change 3-16.97%
S&P500 52-week change 322.36%
52-week high 333.50
52-week low 30.00
50-day moving average 330.98
200-day moving average 331.31

Share statistics

Avg vol (3-month) 33.82k
Avg vol (10-day) 34.58k
Shares outstanding 539.57M
Implied shares outstanding 6N/A
Float 820.35M
% held by insiders 143.20%
% held by institutions 11.83%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.04
Trailing annual dividend yield 30.15%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 315 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 18.55%
Operating margin (ttm)-4.77%

Management effectiveness

Return on assets (ttm)5.58%
Return on equity (ttm)29.19%

Income statement

Revenue (ttm)684.6M
Revenue per share (ttm)17.30
Quarterly revenue growth (yoy)18.70%
Gross profit (ttm)N/A
EBITDA 147.1M
Net income avi to common (ttm)127M
Diluted EPS (ttm)-1.37
Quarterly earnings growth (yoy)1,444.00%

Balance sheet

Total cash (mrq)118.5M
Total cash per share (mrq)2.99
Total debt (mrq)689.8M
Total debt/equity (mrq)138.26%
Current ratio (mrq)1.96
Book value per share (mrq)12.61

Cash flow statement

Operating cash flow (ttm)-2.7M
Levered free cash flow (ttm)-68.74M